Rechsteiner A, Dietrich D, Varga Z (2023) Prognostic relevance of mixed histological subtypes in invasive breast carcinoma: a retrospective analysis. J Cancer Res Clin Oncol 149(8):4967–4978. https://doi.org/10.1007/s00432-022-04443-x
Caldarella A, Buzzoni C, Crocetti E, Bianchi S, Vezzosi V, Apicella P, Biancalani M, Giannini A, Urso C, Zolfanelli F, Paci E (2013) Invasive breast cancer: a significant correlation between histological types and molecular subgroups. J Cancer Res Clin Oncol 139(4):617–623. https://doi.org/10.1007/s00432-012-1365-1
Dieci MV, Orvieto E, Dominici M, Conte P, Guarneri V (2014) Rare breast cancer subtypes: histological, molecular, and clinical peculiarities. Oncologist 19(8):805–813. https://doi.org/10.1634/theoncologist.2014-0108
Han Y, Wang J, Xu B (2020) Clinicopathological characteristics and prognosis of breast cancer with special histological types: a surveillance, epidemiology, and end results database analysis. Breast 54:114–120. https://doi.org/10.1016/j.breast.2020.09.006
WHO (2019) Breast Tumours WHO Classification of Tumours, 5th Edition 2019. International Agency for Research on Cancer. Edited by the WHO Classification of Tumours Editorial Board, Lyon (France)
Fisher ER, Palekar AS, Redmond C, Barton B, Fisher B (1980) Pathologic findings from the national surgical adjuvant breast project (protocol no. 4). VI. Invasive papillary cancer. Am J Clin Pathol 73(3):313–322. https://doi.org/10.1093/ajcp/73.3.313
Siriaunkgul S, Tavassoli FA (1992) Invasive micropapillary carcinoma of the breast. Mod Pathol 6(6):660–662
Liu J, Xi W, Zhou J, Gao W, Wu Q (2023) Nomogram predicting overall prognosis for invasive micropapillary carcinoma of the breast: a SEER-based population study. BMJ Open 13(8):e072632. https://doi.org/10.1136/bmjopen-2023-072632
Böcker W (2002) WHO-klassifikation der tumoren der mamma und des weiblichen genitale: pathologie und genetik [WHO classification of breast tumors and tumors of the female genital organs: pathology and genetics]. Verh Dtsch Ges Pathol 86:116–119
Verras GI, Tchabashvili L, Mulita F, Grypari IM, Sourouni S, Panagodimou E, Argentou MI (2022) Micropapillary breast carcinoma: from molecular pathogenesis to prognosis. Breast Cancer (Dove Med Press) 14:41–61. https://doi.org/10.2147/BCTT.S346301
Akrida I, Mulita F (2022) The clinical significance of HER2 expression in DCIS. Med Oncol 40(1):16. https://doi.org/10.1007/s12032-022-01876-9
Verras GI, Mulita F, Tchabashvili L, Grypari IM, Sourouni S, Panagodimou E, Argentou MI (2022) A rare case of invasive micropapillary carcinoma of the breast. Prz Menopauzalny 21(1):73–80. https://doi.org/10.5114/pm.2022.113834
Wu Y, Zhang N, Yang Q (2017) The prognosis of invasive micropapillary carcinoma compared with invasive ductal carcinoma in the breast: a meta-analysis. BMC Cancer 17(1):839. https://doi.org/10.1186/s12885-017-3855-7
Lewis GD, Xing Y, Haque W, Patel T, Schwartz M, Chen A, Farach A, Hatch SS, Butler EB, Chang J, Teh BS (2019) Prognosis of lymphotropic invasive micropapillary breast carcinoma analyzed by using data from the national cancer database. Cancer Commun (Lond) 39(1):60. https://doi.org/10.1186/s40880-019-0406-4
Huang L, Ji H, Yin L, Niu X, Wang Y, Liu Y, Xuan Q, Li L, Zhang H, Zhou X, Li J, Cui C, Yang Y, An W, Zhang Q (2019) High expression of plakoglobin promotes metastasis in invasive micropapillary carcinoma of the breast via tumor cluster formation. J Cancer 10(12):2800–2810. https://doi.org/10.7150/jca.31411
Gokce H, Durak MG, Akin MM, Canda T, Balci P, Ellidokuz H, Demirkan B, Gorken IB, Sevinc AI, Kocdor MA, Saydam S, Harmancioglu O (2013) Invasive micropapillary carcinoma of the breast: a clinicopathologic study of 103 cases of an unusual and highly aggressive variant of breast carcinoma. Breast J 19(4):374–381. https://doi.org/10.1111/tbj.12128
Meng X, Ma H, Yin H, Yin H, Yu L, Liu L, Li T, Wang S, Xu Q (2021) Nomogram predicting the risk of locoregional recurrence after mastectomy for invasive micropapillary carcinoma of the breast. Clin Breast Cancer 21(4):e368–e376. https://doi.org/10.1016/j.clbc.2020.12.003
Li W, Han Y, Wang C, Guo X, Shen B, Liu F, Jiang C, Li Y, Yang Y, Lang R, Fan Y, Gu F, Niu Y, Zhang X, Zhang L, Wen HY, Fu L (2018) Precise pathologic diagnosis and individualized treatment improve the outcomes of invasive micropapillary carcinoma of the breast: a 12-year prospective clinical study. Mod Pathol 31(6):956–964. https://doi.org/10.1038/s41379-018-0024-8
Yu JI, Choi DH, Huh SJ, Cho EY, Kim K, Chie EK, Ha SW, Park IA, Ahn SJ, Lee JS, Shin KH, Kwon Y, Kim YB, Suh CO, Koo JS, Kim JH, Jeong BG, Kim IA, Lee JH, Park W (2015) Differences in prognostic factors and failure patterns between invasive micropapillary carcinoma and carcinoma with micropapillary component versus invasive ductal carcinoma of the breast: retrospective multicenter case-control study (KROG 13–06). Clin Breast Cancer 15(5):353-361.e1-2. https://doi.org/10.1016/j.clbc.2015.01.008
Eren Kupik G, Altundağ K (2022) The clinicopathological characteristics of pure and mixed invasive micropapillary breast carcinomas: a single center experience. Balkan Med J 39(4):275–281. https://doi.org/10.4274/balkanmedj.galenos.2022.2022-4-7
Zhang T, Lai M, Wei Y, Zhu H, Zhu C, Guo Y, Zeng X (2023) Nomograms for predicting overall survival and cancer-specific survival in patients with invasive micropapillary carcinoma: based on the SEER database. Asian J Surg 46(9):3734–3740. https://doi.org/10.1016/j.asjsur.2023.02.090
Cheng Y, Zhang P, Huang Y, Zhang Z, Tang R, Chi F, Sun JY, He Z (2023) Development and validation of nomograms to predict survival in patients with invasive micropapillary carcinoma of the breast. BMJ Open 13(2):e065312. https://doi.org/10.1136/bmjopen-2022-065312
Chen E, Du Y, Chen Y, Gan Y, Gao H, Hu X, Li Q, Zhang X (2023) A web-based novel model for predicting prognostic value in patients with invasive micropapillary carcinoma in breast cancer: a real-world data retrospective cohort study. Updates Surg 75(7):1997–2004. https://doi.org/10.1007/s13304-023-01530-7
Nurlu D, Saynak M, Özler T, Coşar R (2023) Awareness of invasive micropapillary breast carcinoma is an essential requirement. Balkan Med J 40(2):147–148. https://doi.org/10.4274/balkanmedj.galenos.2023.2023-1-33
Goldhirsch A, Glick JH, Gelber RD, Senn HJ (1998) Meeting highlights: international consensus panel on the treatment of primary breast cancer. J Natl Cancer Inst 90(21):1601–1608. https://doi.org/10.1093/jnci/90.21.1601
Curigliano G, Burstein HJ, Winer EP, Gnant M, Dubsky P, Loibl S, Colleoni M, Regan MM, Piccart-Gebhart M, Senn HJ, Thürlimann B, Panel Members of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2017 (2019) De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen international expert consensus conference on the primary therapy of early breast cancer 2017. Ann Oncol 30(7):1181. https://doi.org/10.1093/annonc/mdy537
Kalbfleisch JD, Prentice RL (1980) The statistical analysis of failure time data. Wiley & Sons Ltd, Hoboken, NJ
Gray RJ (1988) A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat. https://doi.org/10.1214/aos/1176350951
Hao S, Zhao YY, Peng JJ, Ren F, Yang WT, Yu KD, Shao ZM (2019) Invasive micropapillary carcinoma of the breast had no difference in prognosis compared with invasive ductal carcinoma: a propensity-matched analysis. Sci Rep 9(1):286. https://doi.org/10.1038/s41598-018-36362-8
Li G, Yang S, Yao J, Wang Z, Yao G, Liu M, Ye C (2016) Invasive micropapillary carcinoma of the breast had poor clinical characteristics but showed no difference in prognosis compared with invasive ductal carcinoma. World J Surg Oncol 14(1):207. https://doi.org/10.1186/s12957-016-0960-z
Ye F, Yu P, Li N, Yang A, Xie X, Tang H, Liu P (2020) Prognosis of invasive micropapillary carcinoma compared with invasive ductal carcinoma in breast: a meta-analysis of PSM studies. Breast 51:11–20. https://doi.org/10.1016/j.breast.2020.01.041
Magnoni F, Alessandrini S, Alberti L, Polizzi A, Rotili A, Veronesi P, Corso G (2021) Breast cancer surgery: new issues. Curr Oncol 28(5):4053–4066. https://doi.org/10.3390/curroncol28050344
Kim J, Kim JY, Lee HB, Lee YJ, Seong MK, Paik N, Park WC, Park S, Jung SP, Bae SY; Korean Breast Cancer Society (2020) Characteristics and prognosis of 17 special histologic subtypes of invasive breast cancers according to World Health Organization classification: comparative analysis to invasive carcinoma of no special type. Breast Cancer Res Treat 184(2):527–542. https://doi.org/10.1007/s10549-020-05861-6
Lewis GD, Xing Y, Haque W, Patel T, Schwartz MR, Chen AC, Farach A, Hatch SS, Butler EB, Chang JC, Teh BS (2019) The impact of molecular status on survival outcomes for invasive micropapillary carcinoma of the breast. Breast J 25(6):1171–1176. https://doi.org/10.1111/tbj.13432
Hashmi AA, Aijaz S, Mahboob R, Khan SM, Irfan M, Iftikhar N, Nisar M, Siddiqui M, Edhi MM, Faridi N, Khan A (2018) Clinicopathologic features of invasive metaplastic and micropapillary breast carcinoma: comparison with invasive ductal carcinoma of breast. BMC Res Notes 11(1):531. https://doi.org/10.1186/s13104-018-3623-z
留言 (0)